Valuation Fusen Pharmaceutical Company Limited

Stocks

Market Closed - Hong Kong S.E. 04:08:25 2026-10-28 EDT			5-day change	1st Jan Change
0.8800 ^HKD	+2.92%		+11.39%	+10.00%

08-31	Fusen Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-03	Fusen Pharmaceutical Company Limited Selected in National Centralised Medicines Procurement in China	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,952	768.5	959.1	926.5	555.8	531.5
Change	-	-73.96%	24.8%	-3.4%	-40.01%	-4.37%
Enterprise Value (EV) ¹	2,838	927.5	1,059	1,240	923	753.5
Change	-	-67.32%	14.22%	17.09%	-25.59%	-18.37%
P/E	42.9x	50.5x	-25.3x	-24.9x	-2.95x	-45.1x
PBR	4.48x	1.17x	1.56x	1.64x	1.5x	1.48x
PEG	-	-0.7x	0x	-	-0x	0.5x
Capitalization / Revenue	6.06x	1.99x	1.95x	1.64x	1.7x	1.94x
EV / Revenue	5.83x	2.4x	2.15x	2.19x	2.83x	2.76x
EV / EBITDA	29x	11.1x	14.6x	25x	-28.4x	32.3x
EV / EBIT	34.8x	14.1x	23.3x	57.8x	-13.7x	-82.6x
EV / FCF	23.6x	-5.37x	7.02x	-7.8x	20x	6.93x
FCF Yield	4.24%	-18.6%	14.2%	-12.8%	5%	14.4%
Dividend per Share ²	0.0091	0.0091	-	-	-	-
Rate of return	0.24%	0.9%	-	-	-	-
EPS ²	0.0892	0.02	-0.05	-0.05	-0.2551	-0.0159
Distribution rate	10.2%	45.5%	-	-	-	-
Net sales ¹	486.9	385.7	491.8	565.6	326	273.4
EBITDA ¹	97.96	83.35	72.33	49.56	-32.5	23.32
EBIT ¹	81.55	65.92	45.41	21.45	-67.18	-9.122
Net income ¹	70.13	16.64	-34.6	-36.28	-188.8	-11.78
Net Debt ¹	-114	159	100.3	313.9	367.2	222
Reference price ²	3.8313	1.0102	1.2649	1.2436	0.7518	0.7189
Nbr of stocks (in thousands)	770,434	760,744	758,210	745,034	739,301	739,301
Announcement Date	4/23/21	4/28/22	4/28/23	4/26/24	4/30/25	4/30/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FUSEN PHARMACEUTICAL COMPANY LIMITED	-	-	-	-	80.58M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	29.58x	7.09x	18.77x	2.12%	402.76B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%